Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Momenta Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (2675)	12/21/2010 10:29:16 PM
From: Jeffry K. Smith	Read Replies (1) \| Respond to of 3027

Thank you. I am trying to understand the term "immunogenicity" versus the "5 criteria". Wikipedia (ahem) says "Immunogenicity is the ability of a particular substance, such as an antigen or epitope, to provoke an immune response." Okay, so I read that as the ability of a drug to produce a particular reaction in the body - though I don't understand how that can be evaluated without clinical trials. The "5 criteria" is more clear (I hope) to me - they seem to refer to the drug itself and the contents of same - without referencing a human reaction. Am I correct in my suppositions, or can you correct/clear things up? Thank you.